Interleukin-6 could induced malignant transformation of stem cells in association with enhanced signaling of Stat331 and myeloid-derived cells endowed stem-like qualities to breast cancer cells through IL6/STAT3 and NO/NOTCH cross-talk signaling32. This evidence concerns the gene IL6 and breast carcinoma.